Health In Tech (NASDAQ:HIT – Get Free Report) is one of 96 public companies in the “Healthcare Technology” industry, but how does it weigh in compared to its rivals? We will compare Health In Tech to similar companies based on the strength of its earnings, analyst recommendations, valuation, risk, institutional ownership, profitability and dividends.
Profitability
This table compares Health In Tech and its rivals’ net margins, return on equity and return on assets.
| Net Margins | Return on Equity | Return on Assets | |
| Health In Tech | N/A | N/A | N/A |
| Health In Tech Competitors | -768.38% | -39.52% | -18.03% |
Volatility and Risk
Health In Tech has a beta of 2.82, suggesting that its stock price is 182% more volatile than the S&P 500. Comparatively, Health In Tech’s rivals have a beta of 1.12, suggesting that their average stock price is 12% more volatile than the S&P 500.
Earnings and Valuation
| Gross Revenue | Net Income | Price/Earnings Ratio | |
| Health In Tech | $32.83 million | N/A | -14.29 |
| Health In Tech Competitors | $339.33 million | -$23.71 million | 13.22 |
Health In Tech’s rivals have higher revenue, but lower earnings than Health In Tech. Health In Tech is trading at a lower price-to-earnings ratio than its rivals, indicating that it is currently more affordable than other companies in its industry.
Analyst Recommendations
This is a breakdown of recent recommendations and price targets for Health In Tech and its rivals, as provided by MarketBeat.
| Sell Ratings | Hold Ratings | Buy Ratings | Strong Buy Ratings | Rating Score | |
| Health In Tech | 1 | 0 | 1 | 1 | 2.67 |
| Health In Tech Competitors | 431 | 1491 | 2722 | 87 | 2.52 |
Health In Tech presently has a consensus target price of $3.50, suggesting a potential upside of 249.93%. As a group, “Healthcare Technology” companies have a potential upside of 46.70%. Given Health In Tech’s stronger consensus rating and higher possible upside, research analysts plainly believe Health In Tech is more favorable than its rivals.
Institutional & Insider Ownership
41.7% of shares of all “Healthcare Technology” companies are held by institutional investors. 77.7% of Health In Tech shares are held by insiders. Comparatively, 15.9% of shares of all “Healthcare Technology” companies are held by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company is poised for long-term growth.
Summary
Health In Tech beats its rivals on 8 of the 12 factors compared.
Health In Tech Company Profile
Health in Tech, Inc. engages in the provision of insurance technology platforms which offer a marketplace of processes in the healthcare industry. Its services include Stone Mountain Risk, eDIYBS, HI Card, HI Performance Network, and Ancillary Products. The company was founded by Tim Johnson in 2014 and is headquartered in Stuart, FL.
Receive News & Ratings for Health In Tech Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Health In Tech and related companies with MarketBeat.com's FREE daily email newsletter.
